[HTML][HTML] Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications

Z Li, WG Zhu - International journal of biological sciences, 2014 - ncbi.nlm.nih.gov
… investigated to act as cancer chemotherapeutics. The primary … cancer, and further discuss
the underlying mechanisms of anti-tumor activities of HDAC inhibitors and clinical implications. …

Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy

A Borah, S Raveendran, A Rochani, T Maekawa… - Oncogenesis, 2015 - nature.com
Extensive cancer research in the past few decades has identified the existence of a rare
subpopulation of stem cells in the grove of cancer cells. These cells are known as the cancer

Targeting stem cells-clinical implications for cancer therapy

LC Tu, G Foltz, E Lin, L Hood… - … cell research & therapy, 2009 - ingentaconnect.com
… greatest clinical implication evolving around the CSC hypothesis is that one may need to
develop targeted treatment regimes against the unique CSC population for the cure of cancer [7…

Notch1 in cancer therapy: possible clinical implications and challenges

L Gharaibeh, N Elmadany, K Alwosaibai… - Molecular pharmacology, 2020 - ASPET
… an addition to therapeutic strategies recruited for managing cancer. Considering available
… strategies for combating cancer. In this review, the possible clinical applications of Notch1 …

Antibody-drug conjugates for cancer therapy: chemistry to clinical implications

N Dan, S Setua, VK Kashyap, S Khan, M Jaggi… - Pharmaceuticals, 2018 - mdpi.com
cancer therapy. The selection of mAbs for specific targeting and harnessing the therapeutic
… precision acting only on cancer cells, increasing the therapeutic index while minimizing the …

Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy

M Baniyash - Cancer Immunology, Immunotherapy, 2016 - Springer
… has dramatically changed the view of cancer treatment, and numerous novel therapies have
been developed and approved by the FDA. However, cumulative clinical data point at very …

[HTML][HTML] Clinical implications of the cancer genome

LE MacConaill, LA Garraway - Journal of Clinical Oncology, 2010 - ncbi.nlm.nih.gov
… that render complete cancer genome characterization … and clinical insights gleaned from
systematic cancer genome characterization. We also discuss how the convergence of cancer

Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies

A Laviano, MM Meguid, F Rossi-Fanelli - The lancet oncology, 2003 - thelancet.com
Anorexia and reduced food intake are important issues in the management of patients with
cancer because they contribute to the development of malnutrition, increase morbidity and …

Colorectal cancer heterogeneity and targeted therapy: clinical implications, challenges and solutions for treatment resistance

Z Zhai, X Yu, B Yang, Y Zhang, L Zhang, X Li… - Seminars in cell & …, 2017 - Elsevier
… Precision medicine is becoming considerably critical in colorectal cancer therapy. … on
addressing the clinical implication of CRC heterogeneity in anti-EGFR therapies, exploring the …

[HTML][HTML] Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies

JN Bottsford-Miller, RL Coleman… - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
… Angiogenesis has long been considered an important target for cancer therapy. Initial efforts
have primarily focused on targeting of endothelial and tumor-derived vascular endothelial …